Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Analysis of intraocular pressure changes after surgical management of 145 cases of in-the-bag intraocular lens dislocation

Search Title by author or title

Session Details

Session Title: Cataract Surgery Complications: IOL Dislocation and Opacification

Session Date/Time: Tuesday 10/10/2017 | 14:00-16:00

Paper Time: 14:18

Venue: Room 3.6

First Author: : B.Lorente SPAIN

Co Author(s): :    V. De Rojas   M. De La Fuente   P. Vazquez de Parga   R. Lorente           

Abstract Details

Purpose:

To evaluate the changes in intraocular pressure (IOP) after surgical correction of late in the bag IOL dislocation

Setting:

Complexo Hospitalario Universitario de Ourense Complexo Hospitalatio Universitario de A Coruña

Methods:

Retrospective (2005-2014) interventional case series including cases of late spontaneous in-the-bag IOL dislocation from two referral centers. The main outcome measure was preoperative/postoperative intraocular pressure and type of surgery. The secondary outcome measure was glaucoma treatment.

Results:

145 cases for surgery to correct in-the-bag IOL dislocation were identified. Dislocation was grade I in 8 cases (Mean IOP 32.5±13.98). 47 cases were grade II (Mean IOP 21.74±7.75). Grade III in 85 cases (Mean IOP 19.86±7.49) and 13 cases grade IV (Mean IOP 16.92±4.01) Type of surgery: 1) repositioning scleral fixated IOL (SFIOL); 2) IOL exchange for angle supported IOL (ACIOL) or iris claw IOL (ICIOL); 3) IOL removal; 4) capsulotomy. Mean IOP decreased significantly after surgery from 20.78±8.3 to 16.27±4.4 in the whole group (p=0.0001).

Conclusions:

A significant trend towards a decrease in intraocular pressure was found after the surgical management of in the bag dislocated IOLs. This decrease was independent of the technique used to correct the dislocation. IOP tend to decrease as grade of dislocation increase.

Financial Disclosure:

NONE

Back to previous